Consistent with this notion, a recent study reported that PLK1 depletion, mediated by PLK1 siRNA delivered by an antioxidant nanoparticle platform, inhibits lung metastasis and prolongs overall survival in a mouse model of breast cancer metastasis [118]. Here, PLK1 is linked to breast cancer.